Generated by Llama 3.3-70B| CFTR gene | |
|---|---|
| Name | CFTR |
| Locus | 7q31.2 |
CFTR gene is a crucial component in the study of Cystic Fibrosis, a genetic disorder that affects the NIH-estimated 70,000 people worldwide, with significant research contributions from Francis Collins, Craig Venter, and the Human Genome Project. The CFTR gene, located on Chromosome 7, is responsible for encoding the Cystic Fibrosis Transmembrane Conductance Regulator protein, which plays a vital role in regulating the components of Sweat, Mucus, and Digestive enzymes in the body, as studied by UCSF and Stanford University. The gene's dysfunction has been linked to various diseases, including Pancreatitis, Type 1 Diabetes, and COPD, which are areas of focus for the WHO, CDC, and the European Respiratory Society.
CFTR gene The CFTR gene, comprising 27 Exons and spanning approximately 189,000 base pairs, is a member of the ABC transporter family, which includes other genes like ABCA1 and ABCG2, as classified by the NCBI and the EMBL-EBI. The gene's discovery, facilitated by the work of Lap-Chee Tsui, John R. Riordan, and Francis Collins, has led to significant advancements in the understanding of Cystic Fibrosis, a disease that affects the Lung, Pancreas, and other organs, with notable research from Harvard University, University of Oxford, and the University of Cambridge. The CFTR gene's importance extends beyond the realm of Genetic disorders, with implications for the study of Epithelial cells, Ion channels, and Cell signaling pathways, as explored by the American Physiological Society, the Society of General Physiologists, and the Biophysical Society.
The CFTR protein, encoded by the CFTR gene, is a transmembrane Glycoprotein that functions as a Chloride channel, regulating the flow of Chloride ions across Epithelial cell membranes, a process crucial for maintaining proper Fluid balance and pH levels in the body, as studied by UCLA and the University of Chicago. The protein's structure, comprising two Membrane-spanning domains, two Nucleotide-binding domains, and a Regulatory domain, allows it to interact with various molecules, including ATP, ADP, and Phosphorylation sites, as described by the PDB and the UniProt database. The CFTR protein's function is essential for maintaining the proper balance of Salt and water in the body, with dysregulation leading to conditions such as Dehydration and Electrolyte imbalance, which are areas of focus for the AHA and the NKF.
The CFTR gene's clinical significance extends beyond its role in Cystic Fibrosis, with implications for the diagnosis and treatment of various diseases, including Bronchiectasis, Pancreatic cancer, and CBAVD, which are areas of research for the NCI, the ACS, and the ESHRE. The gene's dysfunction has been linked to an increased risk of Respiratory infections, such as Pseudomonas aeruginosa and Staphylococcus aureus, which are major concerns for the CDC and the WHO. The development of CFTR modulators, such as Ivacaftor and Lumacaftor, has revolutionized the treatment of Cystic Fibrosis, with significant improvements in Lung function and Quality of life, as reported by the CFF and the ECFS.
The CFTR gene is inherited in an Autosomal recessive pattern, meaning that an individual must inherit two defective copies of the gene, one from each parent, to express the disease, as described by the NSGC and the ACMG. The gene's Mutations, including Deletion mutations, Insertion mutations, and Point mutations, can be detected using various Genetic testing methods, such as PCR and Sequencing, as developed by Kary Mullis and Fred Sanger. The CFTR gene's Genetic variations have been studied extensively, with significant contributions from the 1000 Genomes Project and the ExAC, which have helped to identify new Disease-causing mutations and Genetic modifiers.
The CFTR gene's regulation and expression are complex processes, involving the interplay of various Transcription factors, Chromatin modifications, and Epigenetic mechanisms, as studied by the NIH and the EMBO. The gene's expression is tissue-specific, with highest levels of expression in the Lung, Pancreas, and Intestine, as reported by the HPA and the GTEx project. The CFTR gene's regulation is also influenced by various Signaling pathways, including the cAMP signaling pathway and the PI3K/AKT signaling pathway, which are areas of research for the ASBMB and the ISSCR.
The CFTR gene's dysfunction has been linked to various disorders and diseases, including Cystic Fibrosis, CBAVD, and Pancreatitis, which are areas of focus for the CFF, the APA, and the EPC. The gene's Mutations have also been associated with an increased risk of Respiratory infections, such as Pseudomonas aeruginosa and Staphylococcus aureus, which are major concerns for the CDC and the WHO. The study of the CFTR gene has also led to a greater understanding of other diseases, including Bronchiectasis, Pancreatic cancer, and Type 1 Diabetes, which are areas of research for the NCI, the ACS, and the ADA. Category:Genetics